Results 341 to 350 of about 18,416,887 (403)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

IGF-1 regulates cancer cell immune evasion in prostate cancer. [PDF]

open access: yesSci Rep
Nandakumar AM   +17 more
europepmc   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Evaluation of the anti-tumor efficacy of prodigiosin in papillary thyroid cancer cell and animal models. [PDF]

open access: yesTransl Oncol
Liu M   +12 more
europepmc   +1 more source

Nucleolar MED19 regulates 2'-O-methylation of rRNA in supporting cancer cell growth. [PDF]

open access: yesNucleic Acids Res
Ming Y   +7 more
europepmc   +1 more source

Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.

open access: green, 2013
Mohammed Talha Shekhani   +3 more
openalex   +1 more source

Nuclear deformation acts as a mechanical switch to drive breast cancer cell migration in a confined microenvironment. [PDF]

open access: yesTheranostics
Wang M   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy